AUG 19, 2026 · PHASE 1 TRIAL
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
ClinicalTrials.gov
This is a Phase 1 interventional trial registration with no results posted; it describes a planned study of semaglutide in alcohol use disorder, not yet recruiting.
Reported
Planned enrollment90
Study phasePhase 1
Primary outcome measureAlcohol use days at 20 weeks